A subgroup analysis based on a paraneoplastic syndrome revealed significant differences in patients with erythrocytosis compared to those without paraneoplastic syndromes in terms of tumor size, albumin, and AFP levels (p < 0.001). The gene discussed is ALB; the disease is neoplasm.